AIDS Orgs Must Disclose All Gilead Grants on Their Sites
(Originally posted at my Facebook campaign site on November 3.)

Recent hearings held by the Board of Supervisors have focused on access to Gilead's HIV drug Truvada for use as a PrEP regimen, but the politicians haven't addressed the price of this drug and Gilead's other HIV and hepatitis medicines.

At the same time, there's been tremendous cheerleading from AIDS service and advocacy organization pushing Truvada as PrEP, and I don't have a problem with that. What I do object to is how AIDS Inc has by and large not demanded lower pricing, and groups receiving Gilead donations have not disclosed financial support from the firm.

It's time to call on our HIV community organizations to create and regularly update transparency pages on their web sites fully disclosing all grants or in-kind gifts from Big Pharma and medical supply companies, and from all corporations. We need to see the amounts given, when they were made and for what purpose they will be used.

In our backyard, the San Francisco AIDS Foundation has received at least $600,000 from Gilead in recent years and their spokesman James Loduca worked for the firm handling public affairs for their HIV drugs (http://tinyurl.com/SFAF-Gilead-Loduca), while IRS 990 filings from Project Inform reveal they've accepted $417,000 from the company (http://tinyurl.com/PI-IRS990-2012 and also http://tinyurl.com/PI-IRS990-FY2013).

These two groups have collaborated to create a social marketing campaign promoting Truvada as PrEP, and like their home web sites, the campaign's site omits mention of robust grants from Gilead (http://tinyurl.com/SFAF-PI-PrEP).

SFAF publishes the BETA newsletter about HIV drug developments and a recent report in it looked at the AIDS Healthcare Foundation's ad campaign opposing Truvada for prevention. Nowhere does BETA disclose SFAF received money from Gilead (http://tinyurl.com/BETA-PrEP-AHF).

In New York City, the Gay Men's Health Crisis has accepted at least $400,000 from Gilead in the past two years and GMHC's Treatment Issues newsletter has also covered Truvada and like BETA failed to disclose the Gilead grants (http://tinyurl.com/GMHC-PrEP). GMHC has also organized PrEP rallies and as far as I can determine, at them doesn't make the Gilead grants transparent to participants.

Back in 2011, SFAF, PI and GMHC signed on to an open letter (http://tinyurl.com/Truvada-Letter-2011), addressed to the FDA and Gilead urging prompt review of regulations that would approve Truvada for PrEP and they weren't the only AIDS organizations that had received Gilead money to add their group's name to the letter. Other groups include:

AIDS Action Committee of Massachusetts (http://tinyurl.com/AAC-Gilead-lunch);
AIDS Foundation of Chicago (http://tinyurl.com/AFC-Gilead-grants);
AIDS Research Consortium of Atlanta (http://tinyurl.com/ARCA-Gilead);
AIDS Vaccine Advocacy Coalition (http://tinyurl.com/AVAC-Gilead);
Black AIDS Institute (http://tinyurl.com/BlackAIDS-Gilead);
Fenway Health.

And these aren't the only HIV nonprofits raking in Gilead money. According to the Gilead Foundation's IRS 990 filings from 2010 through 2012 (http://tinyurl.com/Gilead-990s-GuideStar), and 2013 (http://tinyurl.com/Gilead-IRS990-2013), the following groups received robust six-figure grants:

AIDS Atlanta, $200,000;
AIDS United, $200,000;
Elizabeth Glaser Pediatric AIDS Foundation, $200,000;
Howard Brown Health Center, $400,000;
International AIDS Vaccine Coalition, $200,000;
LA Gay & Lesbian Community Center, $200,000;
Metro Teen AIDS DC, $400,000;
Whitman Walker Clinic, $500,000.

There are dozens of other groups that also accepted Gilead dollars, but in lesser amounts and regardless of the amount, all AIDS nonprofits must become transparent on their sites about the Gilead and all Big Pharma grants.

All medical journals now require financial and conflict of interest disclosures from authors and researchers, which accompanies all articles. We need the same transparency standard from AIDS groups.

If you're pissed off, #VotePetrelis!

Wiener Accepted Gilead's Medical Affairs VP's Donation 
By Todd Swindell and Michael Petrelis

Last month, District 8 incumbent Supervisor Scott Wiener generated lots of media attention after disclosing he's taking Truvada as part of a PrEP regimen to avert contracting HIV.

The disclosure was made in advance of a hearing he and Supervisor David Campos held at City Hall, looking at a supplemental budget allocation to the Department of Public Health in order to investigate educational and cost issues related to Truvada for use for pre-exposure prophylaxis reasons.

We wondered why these gay Supervisors waited more than two-years since the FDA approved Truvada for prevention purposes and how many sexually-transmitted HIV infections occurred in San Francisco in this period that could have been averted if the at-risk individuals had access to PrEP.

A story in the Bay Area Reporter by longtime LGBT health writer Liz Highleyman on the hearing generated a comment from John Steen asking if either Supervisor had received donations from Gilead. Steen seems unaware that such info is a few clicks away.

The SF Ethics Commission's contributions search engine (http://tinyurl.com/SF-Ethics-search-engine),shows that Wiener in 2010 during his first run for Supervisor, received $125 from Hans Reiser who is Gilead's vice president for medical affairs.

We seriously doubt that donation played any role in Wiener pushing for the DPH to receive the Truvada educational allocation, but in the interests of providing transparency between the incumbent and Gilead we're sharing the info since it was omitted from the tremendous coverage last month.